Antioxidant Supplements, Genetics and Chemotherapy Outcomes
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
251-258
Author(s):
Christine B. Ambrosone, Jiyoung Ahn and Vreni Schoenenberger
IP6 & Inositol in Cancer Prevention and Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
259-269
Author(s):
Abul K.M. Shamsuddin and Ivana Vucenik
Experimental Onco-Immunology Revisited
Journal:
Current Cancer Therapy Reviews
Volume:
1
Page:
289-298
Author(s):
Christiane D. Pasqualini, Raul A. Ruggiero, Oscar D. Bustuoabad, Irene Nepomnaschy and Isabel Piazzon
Angiogenesis in Lymphoma: A Short Review
Journal:
Current Molecular Medicine
Volume:
5
Page:
609-613
Author(s):
Anas Younes
Kinases as Drug Discovery Targets in Hematologic Malignancies
Journal:
Current Molecular Medicine
Volume:
5
Page:
625-642
Author(s):
A. L. Hannah
Targeting the Process of Farynesylation for Therapy of Hematologic Malignancies
Journal:
Current Molecular Medicine
Volume:
5
Page:
643-652
Author(s):
Judith E. Karp and Jeffrey E. Lancet
Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Journal:
Current Molecular Medicine
Volume:
5
Page:
653-661
Author(s):
Francis J. Giles and Maher Albitar
Monoclonal Antibodies in the Treatment of Leukemia
Journal:
Current Molecular Medicine
Volume:
5
Page:
663-675
Author(s):
Susan O'Brien, Maher Albitar and Francis J. Giles
Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
471-488
Author(s):
Pouya Pakneshan, Moshe Szyf and Shafaat A. Rabbani
Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
489-503
Author(s):
Donna L. Livant